SOURCES SOUGHT
66 -- Microbiological Incubators. - Microbiological Incubators
- Notice Date
- 6/5/2013
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-13-1119456
- Archive Date
- 6/27/2013
- Point of Contact
- Yolanda T. Peer, Phone: 8705437479
- E-Mail Address
-
yolanda.peer@fda.hhs.gov
(yolanda.peer@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Microbiological Incubators MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), is conducting market research to support the Office of Regulatory Affairs (ORA) requirement for six (6) Microbiological Incubators. The FDA is seeking business sources, including total small businesses, service-disabled veteran-owned small businesses, HUBZone small businesses, 8(a) certified companies and other than small businesses. In addition, the FDA is seeking business sources to determine the availability and capability of small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer. The associated North American Industry Classification System (NAICS) Code is- 334516 - Analytical Laboratory Instrument Manufacturing; Small Business Size Standard of 500 Employees. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort: Background The Office of Reglatory Affairs requires Microbiological Incubators for Microbiological analyses. The incubators are the universal instruments to ensure samples are maintained at the appropriate temperature to permit growth of the target organism if present. Specifications: • Incubator shall have a solid, stainless-steel interior to ensure ease of disinfection and long life • Incubator shall have a heated glass door to minimize condensation • Incubator shall fit an exterior foot print of 33"D x 38"W x 80"H with a capacity of at least 29 cu. Ft. • Incubator shall have at least five (5) heavy-duty, solid stainless-steel shelves • Incubator shall have a directed airflow system which promotes an ideal environment for microbiological applications • Incubator shall have laminar airflow through side plenums to maintain temperature uniformity • Incubator shall have an operating temperature range of 5°C above ambient to 60°C • Incubator shall have an audible/visual under- and over temperature alarms • Incubator shall have data outputs to allow connection to in-house monitor/alarm system to track chamber conditions • Incubator shall have an interior GFCI duplex receptacle on 115V Model for small equipment used within the unit and an exterior receptacle for connecting optional recorder or other equipment • Incubator shall have swivel locking casters to ensure easy mobility • Incubator shall have Power of 115V • Delivery shall be Included Delivery Locations: 1) Food and Drug Administration Winchester Engineering and Analytical Center 109 Holton St Winchester, MA 01890 (2 Incubators) 2) Food and Drug Administration Detroit District Office 300 River Place, Suite 5900 Detroit, MI 48207 (4 Incubators) Responses to this sources sought shall unequivocally demonstrate that respondent is regularly engaged in the manufacture and/or sale of same or substantially similar items. Though the target audience is small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; [Provide this same information again if responding to provide a product manufactured by another firm.] • Three (3) years of past performance information for the manufacture and/or sale of same or substantially similar items to include date of sale, description (should also include drawings and photos), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, marketing material, etc. detailing the nature of the items the responding firm is regularly engaged in manufacturing and/or selling; • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • If a large business, identify the subcontracting opportunities that would exist for small business concerns; and • Though this is not a request for quote, informational pricing is encouraged. The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before June 12, 2013 by 13:00 hours (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OA/OAGS, Attn: Yolanda Peer, 3900 NCTR Road, HFT-320, Jefferson, AR 72079-9502 or email yolanda.peer@fda.hhs.gov. Reference FDA-SOL-13-1119456. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether or not any future requirement similar to this one should be set aside for small business, made available to full and open competition or procure through sole-source acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-13-1119456/listing.html)
- Place of Performance
- Address: Food and Drug Administration, Detroit District Office, 300 River Place, Suite 5900, Detroit, Michigan, 48207, United States
- Zip Code: 48207
- Zip Code: 48207
- Record
- SN03080716-W 20130607/130606001350-98c20a3497dd00b29c2bae02f2cc8440 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |